DC Circ. Backs Boehringer In FTC Atty-Client Privilege Row
Law360 (June 19, 2018, 7:11 PM EDT) -- The D.C. Circuit refused to overturn a ruling that communications subpoenaed from Boehringer Ingelheim Pharmaceuticals Inc. during a Federal Trade Commission pay-for-delay investigation are covered by attorney-client privilege, saying Tuesday one of their main purposes was to get legal advice.
A three-judge panel found that a D.C. federal magistrate judge properly ruled that the documents at issue were protected after privately reviewing them. According to Tuesday's opinion, penned by U.S. Circuit Judge Brett M. Kavanaugh, the documents included communications between executives and Boehringer Ingelheim’s general counsel related to a possible settlement with Barr Pharmaceuticals Inc. over the stroke prevention drug Aggrenox....
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!